Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report

(2023) Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report. Clinical Case Reports. p. 4. ISSN 2050-0904

Full text not available from this repository.

Abstract

Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care. Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis.image

Item Type: Article
Keywords: alemtuzumab DMT epistaxis immune thromboctopenic purpura ITP MS multiple sclerosis RRMS General & Internal Medicine
Page Range: p. 4
Journal or Publication Title: Clinical Case Reports
Journal Index: ISI
Volume: 11
Number: 11
Identification Number: https://doi.org/10.1002/ccr3.8143
ISSN: 2050-0904
Depositing User: خانم ناهید ضیائی
URI: http://eprints.mui.ac.ir/id/eprint/27223

Actions (login required)

View Item View Item